Semaglutide has proven to be a very effective GLP-1 agonist, especially for weight loss and glycaemic control. Semaglutide, in clinical trials, has been found to lower HbA1c (a measure of blood sugar control) and body weight by a significant amount. https://www.coherentmarketinsights.com/blog/semaglutide-vs-other-glp-1-agonists-a-comparative-analysis-1554